Daicel has delivered a 107.9% gain over the past 5 years, which naturally raises the question of whether the current share price around ¥1,436 is still in line with the cash the business can generate. For anyone considering the stock today, the issue is how that share chart stacks up against the intrinsic value implied by its future cash flows.
-
A 107.9% return over 5 years puts a lot of expectation into Daicel's current valuation. The key issue is whether its cash flows can carry that weight.
-
The group's ability to turn earnings into steady free cash flow and manage capital spending efficiently may support or constrain what investors are willing to pay for the shares.
-
If you'd rather focus on earnings, this one's for you. See why Daicel's 37.0x P/E tells a different valuation story .
The stock's next move may depend on whether the Discounted Cash Flow (DCF) view of Daicel's cash flows lines up with where the market is pricing the shares today.
If you are weighing whether Daicel's 107.9% five year return is fairly backed by its cash flows, it can help to compare that question across 14 high quality undervalued stocks .
Is Daicel Still Cheap on Cash Flow?
The Discounted Cash Flow (DCF) model here looks at what Daicel might generate for shareholders over time and treats those future yen as worth less than yen received today. On the latest twelve month view the group reported a free cash outflow of about ¥1.7b, yet the projections used in the DCF assume that cash generation turns positive and then remains at sizeable levels rather than shrinking away.
Those forecasts assume recovering and then steady free cash flows measured in the tens of billions of ¥ a year, which contrasts with the recent outflow. When those future figures are discounted back, the DCF output is meaningfully above the current ¥1,436.00 share price, suggesting the market is not pricing in the full value of the projected cash stream. Find out what Daicel could be worth using our Discounted Cash Flow (DCF) estimate .
The Daicel Narrative: What Would Justify Today's Price?
Narratives on Daicel pick up where that valuation puzzle leaves off and spell out which paths for growth, margins and earnings would need to line up for the stock to be worth materially more or less than today's price on Simply Wall St's Community page. Instead of a single output from a ratio or model, they set out the future conditions that number relies on so you can watch how closely reality tracks those expectations over time.
A clear, written Narrative on Daicel now gives you a single, testable roadmap for where its growth, margins and execution might head compared with what the current share price implies. As actual results come through, that number-driven view can be checked against reality, so you can see which assumptions held up and which ones need to be revised.
Share your own Narrative for Daicel and set out the assumptions behind your valuation.
Daicel's price is only one side of the story
Before treating Daicel's valuation as the whole picture, it is worth knowing that our broader checks have flagged specific concerns that could alter how you view the risk profile of the business. Take a closer look at 4 warning signs (1 major) before settling on a valuation.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include 4202.T .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
